Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
2021 · Molecular Therapy — Oncolytics · 17 citations
https://doi.org/10.1016/j.omto.2021.11.020
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
883
Citations
7
h-index
7
i10-index
Gemma Pidelaserra-Martí is an academic researcher from Witten/Herdecke University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Virus-based gene therapy research & T-cell and B-cell Immunology. The author has an h-index of 7, co-authored 9 publications.
ORCID: 0000-0002-5567-6695Click to start Chat